SARCOPENIA IS A FREQUENT DISEASE IN SARS-COV-2 INFECTION
© Published by Medical Journals Sweden, on behalf of the Foundation for Rehabilitation Information..
Objective: We aimed to investigate the clinical symptoms and specific care requirements of SARS-CoV-2 patients who were admitted to a COVID-19 Rehabilitation Unit while still infectious for SARS-CoV-2 and in the subacute phase of the disease.
Methods: Patients admitted to our COVID-19 Rehabilitation Unit from March 2020 to December 2020 were evaluated for sarcopenia, and they also completed the following assessments: functional independence measure, short physical performance battery and Hamilton Rating Scale for Depression. Age and body mass index and symptoms of dysosmia or dysgeusia were also recorded.
Results: A total of 126 patients were enrolled (50 women, median age 72 years, 18.7 years), of whom 82% of patients presented with low grip strength. Sarcopenia was diagnosed in 52 patients. Sarcopenic patients were older than non-sarcopenic ones (median age 73.4 years, IQR 13.2 vs 63.9 years, IQR 14.5, respectively, p = 0.014). Sarcopenia was associated with the presence of depression (p = 0.008), was more common in women (p = 0.023) and was associated with greater functional deficits (functional independence measure and short physical performance battery analyses, p < 0.05). Sarcopenic patients also had a lower body mass index than other patients (p < 0.01).
Conclusion: More than 40% of our patients suffered from sarcopenia, which was associated with ageing, depression, low body mass index, reduction in functional autonomy and being a woman. Such data provide evidence for the need to assist hospitalized COVID-19 patients by means of a multidisciplinary specialist team.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
Journal of rehabilitation medicine. Clinical communications - 6(2023) vom: 17., Seite 2222 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Iannaccone, Sandro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 11.02.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.2340/jrmcc.v6.2222 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352704977 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352704977 | ||
| 003 | DE-627 | ||
| 005 | 20231226054332.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2340/jrmcc.v6.2222 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1175.xml |
| 035 | |a (DE-627)NLM352704977 | ||
| 035 | |a (NLM)36760715 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Iannaccone, Sandro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARCOPENIA IS A FREQUENT DISEASE IN SARS-COV-2 INFECTION |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.02.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © Published by Medical Journals Sweden, on behalf of the Foundation for Rehabilitation Information. | ||
| 520 | |a Objective: We aimed to investigate the clinical symptoms and specific care requirements of SARS-CoV-2 patients who were admitted to a COVID-19 Rehabilitation Unit while still infectious for SARS-CoV-2 and in the subacute phase of the disease | ||
| 520 | |a Methods: Patients admitted to our COVID-19 Rehabilitation Unit from March 2020 to December 2020 were evaluated for sarcopenia, and they also completed the following assessments: functional independence measure, short physical performance battery and Hamilton Rating Scale for Depression. Age and body mass index and symptoms of dysosmia or dysgeusia were also recorded | ||
| 520 | |a Results: A total of 126 patients were enrolled (50 women, median age 72 years, 18.7 years), of whom 82% of patients presented with low grip strength. Sarcopenia was diagnosed in 52 patients. Sarcopenic patients were older than non-sarcopenic ones (median age 73.4 years, IQR 13.2 vs 63.9 years, IQR 14.5, respectively, p = 0.014). Sarcopenia was associated with the presence of depression (p = 0.008), was more common in women (p = 0.023) and was associated with greater functional deficits (functional independence measure and short physical performance battery analyses, p < 0.05). Sarcopenic patients also had a lower body mass index than other patients (p < 0.01) | ||
| 520 | |a Conclusion: More than 40% of our patients suffered from sarcopenia, which was associated with ageing, depression, low body mass index, reduction in functional autonomy and being a woman. Such data provide evidence for the need to assist hospitalized COVID-19 patients by means of a multidisciplinary specialist team | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a rehabilitation | |
| 650 | 4 | |a sarcopenia | |
| 700 | 1 | |a Brugliera, Luigia |e verfasserin |4 aut | |
| 700 | 1 | |a Spina, Alfio |e verfasserin |4 aut | |
| 700 | 1 | |a Nocera, Gianluca |e verfasserin |4 aut | |
| 700 | 1 | |a Tettamanti, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Giordani, Alessandra |e verfasserin |4 aut | |
| 700 | 1 | |a Angelone, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Castellazzi, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Cimino, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Padul, Jeffrey D |e verfasserin |4 aut | |
| 700 | 1 | |a Houdayer, Elise |e verfasserin |4 aut | |
| 700 | 1 | |a Alemanno, Federica |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of rehabilitation medicine. Clinical communications |d 2018 |g 6(2023) vom: 17., Seite 2222 |w (DE-627)NLM324384289 |x 2003-0711 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2023 |g day:17 |g pages:2222 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2340/jrmcc.v6.2222 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2023 |b 17 |h 2222 | ||